Smart blisters to monitor and support medication adherence: a usability study (SMART BLISTER)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28033

Enrollment

Registered

2021-06-11

Start date

2021-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

All participants receive four MEMS EDP's containing 14 placebo tablets per blister. The placebo tablets are taken out twice daily (not intended to be ingested). The follow-up period is four weeks.

Eligibility

Inclusion criteria

Inclusion criteria: Subjects will be eligible for the trial if all the following criteria are met: • age >18 years • provide informed consent

Exclusion criteria

Exclusion criteria: • Subject informs he/she will not be able to participate in the trial • Withdrawal of informed consent

Design outcomes

Secondary

Measure	Time frame
• Comparison of the MEMS EDP data with manual pill count • Comparison of the MEMS EDP data with self-reported adherence, • Technical assessment • Qualitative evaluation	—

Primary

Measure	Time frame
Usability of the MEMS EDP, measured by the System Usability Scale (SUS)	—

Contacts

Public ContactTanja Zijp

Universitair Medisch Centrum Groningen

t.r.zijp@umcg.nl050-3617876

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)